These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 12975752)

  • 1. Combination and sequential antifungal therapy for invasive aspergillosis: review of published in vitro and in vivo interactions and 6281 clinical cases from 1966 to 2001.
    Steinbach WJ; Stevens DA; Denning DW
    Clin Infect Dis; 2003 Oct; 37 Suppl 3():S188-224. PubMed ID: 12975752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of voriconazole plus amphotericin B or micafungin in a guinea-pig model of invasive pulmonary aspergillosis.
    Chandrasekar PH; Cutright JL; Manavathu EK
    Clin Microbiol Infect; 2004 Oct; 10(10):925-8. PubMed ID: 15373889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of micafungin (FK463) against an itraconazole-resistant strain of Aspergillus fumigatus and a strain of Aspergillus terreus demonstrating in vivo resistance to amphotericin B.
    Warn PA; Morrissey G; Morrissey J; Denning DW
    J Antimicrob Chemother; 2003 Apr; 51(4):913-9. PubMed ID: 12654746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategy of following voriconazole versus amphotericin B therapy with other licensed antifungal therapy for primary treatment of invasive aspergillosis: impact of other therapies on outcome.
    Patterson TF; Boucher HW; Herbrecht R; Denning DW; Lortholary O; Ribaud P; Rubin RH; Wingard JR; DePauw B; Schlamm HT; Troke P; Bennett JE; ;
    Clin Infect Dis; 2005 Nov; 41(10):1448-52. PubMed ID: 16231256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Itraconazole added to a lipid formulation of amphotericin B does not improve outcome of primary treatment of invasive aspergillosis.
    Kontoyiannis DP; Boktour M; Hanna H; Torres HA; Hachem R; Raad II
    Cancer; 2005 Jun; 103(11):2334-7. PubMed ID: 15844093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful medical treatment of cutaneous aspergillosis in a premature infant using liposomal amphotericin B, voriconazole and micafungin.
    Santos RP; Sánchez PJ; Mejias A; Benjamin DK; Walsh TJ; Patel S; Jafri HS
    Pediatr Infect Dis J; 2007 Apr; 26(4):364-6. PubMed ID: 17414408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination antifungal therapy of murine aspergillosis: liposomal amphotericin B and micafungin.
    Graybill JR; Bocanegra R; Gonzalez GM; Najvar LK
    J Antimicrob Chemother; 2003 Oct; 52(4):656-62. PubMed ID: 12972452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment with micafungin of invasive pulmonary aspergillosis in acute myeloid leukemia, with renal failure due to amphotericin B therapy.
    Yokote T; Akioka T; Oka S; Fujisaka T; Yamano T; Hara S; Tsuji M; Hanafusa T
    Ann Hematol; 2004 Jan; 83(1):64-6. PubMed ID: 14661114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of Candida glabrata infection in immunosuppressed mice by using a combination of liposomal amphotericin B with caspofungin or micafungin.
    Olson JA; Adler-Moore JP; Smith PJ; Proffitt RT
    Antimicrob Agents Chemother; 2005 Dec; 49(12):4895-902. PubMed ID: 16304150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poor efficacy of amphotericin B-based therapy in CNS aspergillosis.
    Schwartz S; Ruhnke M; Ribaud P; Reed E; Troke P; Thiel E
    Mycoses; 2007 May; 50(3):196-200. PubMed ID: 17472616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination therapy with micafungin and amphotericin B for invasive pulmonary aspergillosis in an immunocompromised mouse model.
    Nagasaki Y; Eriguchi Y; Uchida Y; Miyake N; Maehara Y; Kadowaki M; Harada M; Akashi K; Shimono N
    J Antimicrob Chemother; 2009 Aug; 64(2):379-82. PubMed ID: 19465436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined antifungal therapy in a murine infection by Candida glabrata.
    Mariné M; Serena C; Pastor FJ; Guarro J
    J Antimicrob Chemother; 2006 Dec; 58(6):1295-8. PubMed ID: 17012301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Curative treatment of invasive aspergillosis].
    Dupont B
    Pathol Biol (Paris); 1994 Sep; 42(7):688-93. PubMed ID: 7877863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro interaction of micafungin with conventional and new antifungals against clinical isolates of Trichosporon, Sporobolomyces and Rhodotorula.
    Serena C; Mariné M; Pastor FJ; Nolard N; Guarro J
    J Antimicrob Chemother; 2005 Jun; 55(6):1020-3. PubMed ID: 15845779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical efficacy of micafungin for chronic pulmonary aspergillosis.
    Izumikawa K; Ohtsu Y; Kawabata M; Takaya H; Miyamoto A; Sakamoto S; Kishi K; Tsuboi E; Homma S; Yoshimura K
    Med Mycol; 2007 May; 45(3):273-8. PubMed ID: 17464848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of invasive central nervous system aspergillosis treated with micafungin with monitoring of micafungin concentrations in the cerebrospinal fluid.
    Okugawa S; Ota Y; Tatsuno K; Tsukada K; Kishino S; Koike K
    Scand J Infect Dis; 2007; 39(4):344-6. PubMed ID: 17454899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination antifungal therapy: where are we now, and where are we going?
    Marr K
    Oncology (Williston Park); 2004 Nov; 18(13 Suppl 7):24-9. PubMed ID: 15651179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination antifungal therapy for invasive aspergillosis: utilizing new targeting strategies.
    Steinbach WJ
    Curr Drug Targets Infect Disord; 2005 Sep; 5(3):203-10. PubMed ID: 16181140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Echinocandin antifungal drugs.
    Denning DW
    Lancet; 2003 Oct; 362(9390):1142-51. PubMed ID: 14550704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of current drug therapies for invasive aspergillosis.
    Traunmüller F; Popovic M; Konz KH; Smolle-Jüttner FM; Joukhadar C
    Pharmacology; 2011; 88(3-4):213-24. PubMed ID: 21986253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.